Emerging Targeted Immunotherapies Show Promise for Graves' Disease Beyond Standard Antithyroid Drugs
<p>A comprehensive 2025 review summarizes emerging targeted therapies for Graves' disease that go beyond antithyroid drugs, radioiodine, and...
View »